Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | R1279Q |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | ALK R1279Q lies within the protein kinase domain of the Alk protein (UniProt.org). R1279Q is not transforming in culture (PMID: 33674381) but results in tumor formation in the context of Mycn overexpression in mouse models (PMID: 24811913), but has not been fully biochemically characterized and therefore, its effect on Alk protein function is unknown. |
| Associated Drug Resistance | |
| Category Variants Paths |
ALK mutant ALK R1279Q |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29209786_29209787delAGinsCA |
| cDNA | c.3835_3836delAGinsCA |
| Protein | p.R1279Q |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.5 | chr2:g.29209786_29209787delAGinsCA | c.3835_3836delAGinsCA | p.R1279Q | RefSeq | GRCh38/hg38 |
| NM_004304.4 | chr2:g.29209786_29209787delAGinsCA | c.3835_3836delAGinsCA | p.R1279Q | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|